HealthMDMA therapies hit a roadblock – what's next? The US Food and Drug Administration has rejected the psychedelic drug MDMA as a treatment for post-traumatic stress disorder, leading many to wonder whether psychedelic therapies have a future in medicine News
HealthAppetite for mind-altering substances is booming among US adults Rates of cannabis and psychedelic use among adults in the US reached record highs in 2022, part of a decade-long upswing in the use of mind-altering drugs News